首页> 外文期刊>Haematologica >Short-term, serum-free, static culture of cord blood-derived CD34+ cells: effects of FLT3-L and MIP-1alpha on in vitro expansion of hematopoietic progenitor cells | Haematologica
【24h】

Short-term, serum-free, static culture of cord blood-derived CD34+ cells: effects of FLT3-L and MIP-1alpha on in vitro expansion of hematopoietic progenitor cells | Haematologica

机译:脐血来源的CD34 +细胞的短期,无血清静态培养:FLT3-L和MIP-1alpha对造血祖细胞体外扩增的影响|血液学

获取原文
       

摘要

BACKGROUND AND OBJECTIVE: The use of ex vivo expanded cells has been suggested as a possible means to accelerate the speed of engraftment in cord blood (CB) transplantation. The aim of this study was to fix the optimal condition for the generation of committed progenitors without affecting the stem cell compartment. DESIGN AND METHODS: Analysis of the effects of FLT3-L and MIP-1alpha when combined with SCF, IL-3 and IL-6, in short-term (6 days), serum-free expansion cultures of CB-selected CD34+ cells. RESULTS: An important expansion was obtained that ranged between 8-15 times for CFU-GM, 21-51 times for the BFU-E/CFU-Mix population and 11 to 30 times for CD34+ cells assessed by flow cytometry. From the combinations tested, those in which FLT3-L was present had a significant increase in the expansion of committed progenitors, while the presence of MIP-1alpha had a detrimental effect on the generation of more differentiated cells. However, stem cell candidates assessed by week 5 CAFC assay could be maintained in culture when both MIP-1a and FLT3-L were present (up to 91% recovery). This culture system was also able to expand megakaryocytic precursors as determined by the co-expression of CD34 and CD61 antigens (45-70 times), in spite of the use of cytokines non-specific for the megakaryocytic lineage. INTERPRETATION AND CONCLUSIONS: The results obtained point to the combination of SCF, IL-3, IL-6, FLT3-L and MIP-1alpha as the best suited for a pre-clinical short-term serum-free static ex vivo expansion protocol of CB CD34+ cells, since it can generate large numbers of committed progenitor cells as well as maintaining week 5 CAFC.
机译:背景与目的:已提出使用体外扩增的细胞作为加快脐带血(CB)移植的植入速度的可能手段。这项研究的目的是在不影响干细胞区室的情况下,确定产生定型祖细胞的最佳条件。设计与方法:分析短期(6天)CB选择的CD34 +细胞无血清扩增培养物中FLT3-L和MIP-1alpha与SCF,IL-3和IL-6结合的作用。结果:通过流式细胞术评估,获得的重要扩增范围为CFU-GM的8-15倍,BFU-E / CFU-Mix群体的21-51倍和CD34 +细胞的11至30倍。从测试的组合来看,其中存在FLT3-L的组合显着增加了定型祖细胞的扩增,而MIP-1alpha的存在则对更多分化细胞的产生产生了不利影响。但是,当同时存在MIP-1a和FLT3-L时,通过第5周CAFC分析评估的干细胞候选物可以保留在培养物中(回收率高达91%)。尽管使用了对巨核细胞谱系非特异性的细胞因子,但这种培养系统也能够扩增由CD34和CD61抗原的共表达所确定的巨核细胞前体(45-70次)。解释和结论:获得的结果表明,SCF,IL-3,IL-6,FLT3-L和MIP-1alpha的组合最适合临床前短期无血清静态离体扩增方案CB CD34 +细胞,因为它可以生成大量定型祖细胞并维持第5周的CAFC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号